Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1994 | 12-1993 | 09-1993 | 06-1993 | 03-1993 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90 | 0 | 0 | 0 | 0 |
| Marketable Securities | 0 | 140 | 0 | 0 | 0 |
| Receivables | 4,390 | 4,540 | 0 | 0 | 0 |
| Inventories | 2,510 | 2,470 | 0 | 0 | 0 |
| Other current assets | 300 | 470 | 0 | 0 | 0 |
| TOTAL | $7,290 | $7,620 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| Investments And Advances | 80 | 0 | 0 | 0 | 0 |
| TOTAL | $80 | $0 | $0 | $0 | $0 |
| Total Assets | $8,960 | $9,300 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 70 | 70 | 0 | 0 | 0 |
| Other current liabilities | 640 | 1,020 | 0 | 0 | 0 |
| TOTAL | $6,680 | $7,000 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 50 | 60 | 0 | 0 | 0 |
| TOTAL | $50 | $60 | $0 | $0 | $0 |
| Total Liabilities | $6,730 | $7,060 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Common Shares | 2 | 2 | 0 | 0 | 0 |
| Retained earnings | 810 | 790 | 0 | 0 | 0 |
| Other shareholders' equity | 8 | 8 | 0 | 0 | 0 |
| TOTAL | $1,740 | $1,720 | $0 | $0 | $0 |
| Total Liabilities And Equity | $8,470 | $8,780 | $0 | $0 | $0 |